Update on the management of alcohol use disorders

Abstract

SUMMARYAlcohol use disorders (AUD) are common, particularly in patients attending mental health services. Clinicians are often hesitant to explore with patients their relationship with alcohol and the role that it has in their presenting complaint, despite being ideally placed to optimise on a ‘teachable moment’ and initiate treatment, where necessary. This article provides an overview of AUD and their identification and management options.

19th Latest Advances in Psychiatry International Symposium

“…It can trigger hypomanic states and there is a risk of respiratory depression in overdose. So it needs to be prescribed with caution and preferably by clinicians experienced in its use 38 …”

“…So it needs to be prescribed with caution and preferably by clinicians experienced in its use. 38 It is important to treat both depression and alcohol misuse not just one or the other. Patients treated with naltrexone and sertraline had significantly better outcomes than those treated with sertraline or naltrexone alone.…”

Glutamate as a Target Therapy for Alcohol Dependence Disorder

“…Economically, The cost society of AUDs each year about 200 billion dollars (3). The important features for diagnosing of AUDs and for advancing treatment strategies are depended on the extent of alcohol consumption and volume consumed per unit time (4,5). The pharmacological efficacy for treatment of AUDs is altered by genotypic and/or phenotypic characteristics associated with drinking typologies and development of AUD by enhancing excessive early alcohol drink was observed through many of the gene variants (6,7).…”